PortViewPortView
CDT Equity logo

CDT Equity (CDTTW) Stock Analysis

NASDAQHealthcareBiotechnology

$0.01+0.00%
1-year price historyRange $0.01 – $0.02
52-week range$0.01
$0.01$0.01

What CDT Equity does

CDT Equity Inc., established in October 2021 by David Joszef Tapolczay and Freda C. Lewis-Hall, operates from its headquarters in Naples, Florida, with a core mission to advance the development and market introduction of clinical assets.

Key metrics

Market cap
$17,601
Beta
1.46
Dividend yield
0.00%
Revenue / share
$37.20
50-day avg
$0.01
200-day avg
$0.01
52-week high
$0.01
52-week low
$0.01
CEO
Andrew Regan

ETFs linked to CDTTW

Broad-market and Healthcare sector ETFs an investor holding CDT Equity is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how CDTTW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CDTTW in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for CDT Equity?
CDT Equity trades under the ticker CDTTW on NASDAQ.
Which exchange is CDTTW listed on?
CDTTW is listed on NASDAQ.
What sector does CDT Equity operate in?
CDT Equity is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CDTTW in a portfolio?
PortView shows CDTTW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.